Literature DB >> 14734654

Minimal mutations are required to effect a radical change in function in CEA family members of the Ig superfamily.

Fakhraddin Naghibalhossaini1, Clifford P Stanners.   

Abstract

GPI anchorage in the CEA family results in the acquisition of radically different functions relative to TM anchorage, including inhibition of differentiation and anoikis, disruption of tissue architecture and promotion of tumorigenicity. CEA GPI anchors, as determined by the carboxy-terminal exon of CEA, demonstrate biological specificity in their ability to confer these functional changes. CEA family GPI anchorage appears to have evolved twice independently during the primate radiation, in a manner suggestive of evolution from more primitive TM-anchored CEACAM1. We show here that very few mutations in the TM exon of present-day human CEACAM1 are required to give efficient GPI anchorage and the biological specificity of CEA GPI anchors, i.e., to give the differentiation-blocking function of GPI-anchored CEA. Such a change in anchorage could therefore represent a relatively facile means for producing radical change in molecular function of Ig superfamily members during evolution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734654     DOI: 10.1242/jcs.00903

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  11 in total

1.  Coevolution of activating and inhibitory receptors within mammalian carcinoembryonic antigen families.

Authors:  Robert Kammerer; Wolfgang Zimmermann
Journal:  BMC Biol       Date:  2010-02-04       Impact factor: 7.431

2.  Evolution of a tumorigenic property conferred by glycophosphatidyl-inositol membrane anchors of carcinoembryonic antigen gene family members during the primate radiation.

Authors:  Fakhraddin Naghibalhossaini; Anne D Yoder; Martin Tobi; Clifford P Stanners
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

3.  Bm86 homologues and novel ATAQ proteins with multiple epidermal growth factor (EGF)-like domains from hard and soft ticks.

Authors:  Ard M Nijhof; Jesper A Balk; Milagros Postigo; Anne Marie Rhebergen; Amar Taoufik; Frans Jongejan
Journal:  Int J Parasitol       Date:  2010-07-18       Impact factor: 3.981

4.  Identification of a novel functional specificity signal within the GPI anchor signal sequence of carcinoembryonic antigen.

Authors:  Thomas B Nicholson; Clifford P Stanners
Journal:  J Cell Biol       Date:  2007-04-16       Impact factor: 10.539

5.  A comprehensive phylogenetic and structural analysis of the carcinoembryonic antigen (CEA) gene family.

Authors:  Athanasia Pavlopoulou; Andreas Scorilas
Journal:  Genome Biol Evol       Date:  2014-05-23       Impact factor: 3.416

Review 6.  The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches.

Authors:  Joo Han Lee; Seong-Wook Lee
Journal:  Gastroenterol Res Pract       Date:  2017-05-10       Impact factor: 2.260

7.  Evolutionary descent of prion genes from the ZIP family of metal ion transporters.

Authors:  Gerold Schmitt-Ulms; Sepehr Ehsani; Joel C Watts; David Westaway; Holger Wille
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

8.  Species-specific evolution of immune receptor tyrosine based activation motif-containing CEACAM1-related immune receptors in the dog.

Authors:  Robert Kammerer; Tanja Popp; Stefan Härtle; Bernhard B Singer; Wolfgang Zimmermann
Journal:  BMC Evol Biol       Date:  2007-10-18       Impact factor: 3.260

9.  Alternative splicing after gene duplication drives CEACAM1-paralog diversification in the horse.

Authors:  Sophie Mißbach; Denis Aleksic; Lisa Blaschke; Timm Hassemer; Kyung Jin Lee; Martin Mansfeld; Jana Hänske; Johannes Handler; Robert Kammerer
Journal:  BMC Evol Biol       Date:  2018-03-15       Impact factor: 3.260

Review 10.  Neuronal zinc regulation and the prion protein.

Authors:  Nicole T Watt; Heledd H Griffiths; Nigel M Hooper
Journal:  Prion       Date:  2013 May-Jun       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.